DHEA Micronized 25 mg by XYMOGEN — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
Limited research evidence available for ingredients

B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size

60 Servings

Non-Nutrient/Non-Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Dehydroepiandrosterone, Micronized

25 mg

📊 Market median: 50.0mg (57 products) 📚 17 studies — no high-quality reviews

This product: 25mg UL 50mg

Other Ingredients

Dicalcium Phosphate Dihydrate Microcrystaline Cellulose Croscarmellose Sodium Ascorbyl Palmitate Hydroxypropyl Cellulose Silica Coating

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (72% of products) Nutrient (2% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions: Take one tablet twice daily, or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Individuals taking medication should discuss potential interactions with their healthcare professional.

Do not use if tamper seal is damaged.

Warning: Not for use by individuals under the age of 18 years.

Do not use if pregnant or nursing.

Consult a physician or licensed, qualified healthcare professional before using this product if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low “good” cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed, qualified healthcare professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms.

Keep out of reach of children.

🧪 Formulation Notes

Formulated to Exclude: Wheat, gluten, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Supports healthy androgen and estrogen levels

Additional Information

Professional Use Only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

Exclusive Professional Formulas

ePV

Third-Party Verified GMP Compliant

Third-Party Verified GMP Compliant This package is completely recyclable

Product Details

UPC / SKU 8 71149 00731 7

DSLD Entry Date 2020-11-21

Product Type Non-Nutrient/Non-Botanical

Form Tablet or Pill

Brand XYMOGEN

DSLD ID 240168

Data Updated 2026-04-11

Research Evidence

30 Research Sources

49 Avg Quality Score

21 Rct

5 Meta Analysis

2 Systematic Review

1 Other

1 Guideline

A Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction

Meta Analysis The Cochrane database of systematic reviews 2024

PubMed DOI Cochrane

B Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis

Meta Analysis Annals of medicine 2025

PubMed DOI

B Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials

Meta Analysis Complementary therapies in medicine 2021

PubMed DOI

B Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.

Guideline Ginekologia polska 2020

PubMed DOI

B Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis

Rct The Journal of clinical endocrinology and metabolism 2016

PubMed DOI

C Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients

Rct The Journal of clinical endocrinology and metabolism 2008

PubMed DOI

C Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.

Rct The lancet. Healthy longevity

PubMed DOI

C Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA)

Rct Clinica chimica acta; international journal of clinical chemistry 2014

PubMed DOI

C Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement

Rct The Journal of clinical endocrinology and metabolism 2006

PubMed

View all evidence for Dhea →